Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2010

Mar 2, 2010

29831_dirs_2010-03-01_a8c7ba22-9052-4e7b-b923-41a656a9d858.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2010-02-25

Reporting Person: READ IAN C (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-02-25 Common Stock A 84959 Acquired 562254 Direct
2010-02-25 Common Stock A 4581 Acquired 566835 Direct
2010-02-25 Common Stock F 1617 $17.69 Disposed 565218 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-02-25 Stock Appreciation Rights $17.69 A 197072 Acquired 2015-02-25 Common Stock (197072) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6272 Indirect

Footnotes

F1: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.

F2: The reported transaction constitutes the earn-out of Performance-Contingent Shares.

F3: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance-Contingent Shares.

F4: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.